Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer
KRAS-MAPK 通路抑制剂与 HER2 靶向药物偶联物联合治疗胰腺癌有效
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-024-46811-w
Ashenafi Bulle #, Peng Liu #, Kuljeet Seehra, Sapana Bansod, Yali Chen, Kiran Zahra, Vikas Somani, Iftikhar Ali Khawar, Hung-Po Chen, Paarth B Dodhiawala, Lin Li, Yutong Geng, Chia-Kuei Mo, Jay Mahsl, Li Ding, Ramaswamy Govindan, Sherri Davies, Jacqueline Mudd, William G Hawkins, Ryan C Fields, Davi